Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Novus Biologicals™ Recombinant Human KLF4 His Protein
Highly purified. Generating reliable and reproducible results. Applications: SDS-Page
$398.00 - $1110.00
Specifications
Concentration | 1mg/mL |
---|---|
For Use With (Application) | SDS-PAGE |
Formulation | 20mM Tris-HCl buffer (pH 8.0) containing 10% glycerol |
Gene ID (Entrez) | 9314 |
Molecular Weight (g/mol) | TMW: 44.2kDa |
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
NBP25201401
|
Novus Biologicals™
NBP2520140.1MG |
0.1mg |
Each for $398.00
|
|
|||||
NBP25201405
|
Novus Biologicals™
NBP2520140.5MG |
0.5mg |
Each for $1,110.00
|
|
|||||
Description
A denatured recombinant protein with a N-Terminal His-tag and corresponding to the amino acids 11-395 of Human KLF4 The Recombinant Human KLF4 Protein is derived from E. coli. The Recombinant Human KLF4 Protein has been validated for the following applications: SDS-Page.Specifications
1mg/mL | |
20mM Tris-HCl buffer (pH 8.0) containing 10% glycerol | |
TMW: 44.2kDa | |
Epithelial zinc finger protein EZF, EZFendothelial Kruppel-like zinc finger protein, GKLFKrueppel-like factor 4, Gut-enriched krueppel-like factor, Kruppel-like factor 4 (gut) | |
Unconjugated | |
>85%, by SDS-PAGE |
SDS-PAGE | |
9314 | |
Store at 4°C short term. Aliquot and store at −20°C long term. Avoid freeze-thaw cycles. | |
KLF4 | |
Recombinant |
For research use only and is not approved for use in humans or in clinical diagnosis
Spot an opportunity for improvement?
Provide Content Correction
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title